- 08/2012 - News Article - Gad M. Gilad, PhD, "Agmatine Attenuates Sciatic & Other Neuro...". Holistic Primary Care, August 2018, Online Issue.
- 07/12-14/2018 - Product Exhibition - Gilad&Gilad feature AgmaSet® at the American Association of Naturopathic Physicians 2018 Annual Conference in San Diego, California; the largest professional meeting of Naturopathic Doctors.
- 03/09-11/2018 - Product Exhibition - Gilad&Gilad featured AgmaSet® and AgmaVet® at Natural Products Expo West in Anaheim, California; the largest business trade show for dietary supplements.
- 03/01-03/2018 - Product Exhibition - Gilad&Gilad featured AgmaSet® and AgmaVet® at the Parker Seminar in Las Vegas, Nevada; the largest professional meeting of Doctors of Chiropractic.
- 01/09/2018 - Trademark Registration - AgmaVet® was officially registered as a trademark by the United States Patent and Trademark Office (USPTO).
- 06/23/2017 - Product Exhibition - Gilad&Gilad featured AgmaSet® at the "Neuropathy Action Awareness Day" in Los Angeles, California.
- 04/2017 - Press Release - "Another Agmatine Patent for Gilad&Gilad."
- 03/07/2017 - New Patent - Gilad Gad and Gilad Varda received US Patent No. 9,585,852 B2, a continuation patent titled "Agmatine Containing Dietary Supplements, Nutraceuticals and Foods".
- 02/20/2017 - Relocation to Henderson, Nevada - Press Release - "Gilad&Gilad Gambles on Las Vegas".
- 07/02/2016 - Price Reduction - New retail price of a 120-count bottle has been reduced to $49.99 (previously $59.99). Made possible as a result of reduced production costs.
- 03/01/2016 - Press Release - "AgmaSet for Nerve Health Launched in the Philippines".
- 01/29/2016 - News Article - Hank Schultz, "Gilad&Gilad successfully defends usage patents for agmatine in nerve health". NutraIngredients-USA.com, Breaking News on Supplements & Nutrition, 2/4/2016.
- 01/26/2016 - Press Release - "Gilad&Gilad Successfully Defends Agmatine Patents".
- 12/2014 - New Patent - Gilad Gad and Gilad Varda received US Patent No. 8916612 (issued 12/23/2014) titled "Agmatine Containing Dietary Supplements, Nutraceuticals and Foods".
- 07/2014 - Scientific Publication - Case Study by Gilad GM and Gilad VH, "Long-term (5 years), high daily dosage of dietary agmatine - Evidence for safety: A case report", Journal of Medicinal Food 17 (11):1256-1259, 2014.
- 05/01/2014 - Scientific Communication - American Academy of Neurology 66th Annual Meeting, Philadelphia, PA: Tohidi et al., "Effects of agmatine sulfate in... small fiber..." (Scientific Abstract # 4082; Poster # P7.094).
- 04/28/2014 - News Article - Engredea News & Analysis: "New study backs oral agmatine for neuro...".
- 10/2013 - Scientific Publication - by Gilad GM and Gilad VH, "Evidence for oral agmatine sulfate safety - A 95-day high dosage pilot study with rats", Food and Chemical Toxicology 62:758-762, 2013.
- 09/20/2013 - News Article - Hank Schultz, "Developers think neuroprotective compound Agmatine is finally ready for prime time". NutraIngredients-USA.com, Breaking News on Supplements & Nutrition, 19-Sep-2013 to 26-Sep-2013.
- 09/2013 - Scientific Publication - Review Article by Piletz JE et al., "Agmatine: clinical applications after 100 years in translation", Drug Discovery Today 18 (17/18):880-893, 2013.
- 05/02/2013 - Price Reduction - New retail price of a 120-count bottle has been reduced to $59.99 (previously $64.99).
- 01/30-02/02/2013 - Product Exhibition and Scientific Communications -Gilad&Gilad featured AgmaSet® at the "Scripps - 10th Anniversary Natural Supplements Conference", San Diego, California. Posters with Honorable Mention: (1) Gilad GM and Gilad VH, "Agmatine - Utility as a Nutraceutical...". (2) Sherwood K et al., "Agmatine - Effectiveness in .... A Pilot Study", cited in J Alternat Complement Med 19(6):A9 and A10, 2013.
- 08/2012 - News Article - Michele Cagan, "Breaking news: Pioneer scientists uncover the Holy Grail lifesaver for...". Health Sciences Institute (HSI), 17 (2), August 2012 Issue, pp 4-5, 8 (http://www.HSIonline.com).
- 06/2012 - News Article - Janet Poveromo , "...Nerve... ". Natural Practitioner, June 2012 Issue, p 31 (http://www.naturalpractitionermag.com).
- 05/14/2012 - Press Release - Engredea News & Analysis: "New book features AgmaSet® ingredient research".
- 04/24/2012 - Press Release - Engredea News & Analysis: "Gilad&Gilad launches AgmaVet(TM) for animal food".
- 04/13/2012 - Press Release - PRWeb; Engredea News & Analysis: "AgmaSet® - Gilad&Gilad rebrand their leading supplement for nerve ... functions".
- 03/04/2012 - Radio Interview with our CEO - Progressive Radio Network - Dr. Sherrill Sellman Radio Show What Women Must Know - on "A New Solution For..." http://prn.fm/category/archives/ what-women-must-know/.
- 02/24-25/2012 - Scientific Communication - Gilad GM and Gilad VH presented a poster on: "Agmatine - A Century-Old Newcomer for...", at the American Academy of Pain Medicine, 28th Annual Meeting, Palm Spring, California: (Poster # 285).
- 02/10-11/2012 - Product Exhibition - Gilad&Gilad featured NeurofencineTM at the Integrative Healthcare Symposium in New York, New York.
- 01/19-21/2012 - Product Exhibition - Gilad&Gilad featured Neurofencine(TM) at the Parker Chiropractic Seminars in Las Vegas, Nevada.
- Book Chapter about AgmaSet® (Neurofencine(TM)), Published October 2011 - "Banish ... with this miraculous, little-known supplement. Works by protecting and strengthening your nerve cells." In: Breakthroughs in Natural Healing 2012. By: Bill Gottlieb. Bottom Line Publications, page 14.
- Product Exhibition (10/12-14/2011) - Gilad&Gilad showcase of Neurofencine(TM) at the California Naturopathic Doctors Association (CNDA) Conference in Newport Beach, California.
- Interview with our CEO (07/22/2011)- Nutraceuticals World - Sheldon Baker Interviews Industry Influencers: "An Interview with Dr. Gad Gilad".
- Trademark Registration (07/19/2011) - AgmaSet® was officially registered as a trademark by the United States Patent and Trademark Office (USPTO).
- Marketing & Distribution - (May, 2011) Export to Singapore.
- Trademark Registration (02/01/2011) - G-Agmatine® was officially registered as a trademark by the United States Patent and Trademark Office (USPTO).
- Press Release (01/19/2011) - NPI Daily: "Gilad&Gilad Exhibits Neurofencine(TM) -A Supplement for Nerve ... Functions- at the Neuropathy Summit" .
- Product Exhibition (12/03-04/2010) - Gilad&Gilad exhibited Neurofencine(TM) at the 'Neuropathy Summit' in Washington DC. www.neuropathy.org.
- Press Release (11/02/2010) - NPI Daily: "Gilad&Gilad's G-agmatine Featured in Pain Medicine Journal".
- News Article (October 2010) - Laura Tendler, "Dietary Supplement Agmatine Beneficial in...". Pain Medicine News, Vol. 8(10):19, 2010 (Published Online: http://www.painmedicinenews.com/).
- Product Exhibition (10/09-10/2010) - Gilad&Gilad showcase of Neurofencine(TM) at the California Naturopathic Doctors Association (CNDA) Conference in Marina del Ray, California.
- Press Release (08/16/2010) - Medical Daily: "Dietary agmatine - ... and improving health-related quality of life in...".
- Product Exhibition (08/12-14/2010) - Gilad&Gilad exhibited NeurofencineTM at the American Association of Naturopathic Physicians 25th Anniversary Convention (Booth #711) in Portland, Oregon.
- Press Release (08/10/2010) - Nutraceuticals World: "Neurofencine".
- Press Release (07/20/2010) - NPI Daily: "G&G's G-agmatine(TM) Reviewed in Chiropractic Publication".
- Professional Publication (07/15/2010) - Gilad GM, Gilad VH. "Dietary Agmatine...". ACAnews - official publication of the American Chiropractic Association (www.acatoday.org) July, 2010, issue.
- Press Release (04/28/2010) - NPI Daily: "Clinical Studies on Gilad&Gilad's G-agmatine(TM) Featured at American Academy of Neurology Meeting".
- Scientific Communication (04/15/2010) - American Academy of Neurology 62nd Annual Meeting, Toronto, Canada: Gilad et al., "Efficacy of Dietary Agmatine Sulfate in... Lumbar Disc-Associated... A Randomized, Double-Blind, Placebo-Controlled Study" (Poster # PO5.144).
- Scientific Honorary Mention (04/13/2010) - Gilad et al. landmark clinical studies on G-agmatine(TM) were chosen and presented at the "Highlights in the Field of Spine" by the American Academy of Neurology during its 62nd Annual Meeting in Toronto, Canada.
- Product Exhibition (03/12-14/2010) - Gilad&Gilad first trade show. Neurofencine(TM) showcased at the Natural Products Expo West (Booth #1011) in Anaheim Convention Center, Anaheim, California.
- Press Release (03/10/10) - NutraIngredients-USA.com News Headlines: "Study links... improved nerve health to agmatine".
- Scientific Publication (03/02/2010) - Keynan O, Mirovsky Y, Dekel S, Gilad VH, Gilad GM. "Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-Associated ... An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial". Pain Medicine 11:356-368, 2010 (Published Online: March 2, 2010).
- Press Release (02/25/2010) - Gilad&Gilad first press release. NPI Daily: "Introducing NeurofencineTM containing G-agmatine(TM)".
- Sales Start - February 1, 2010.
- Launching Neurofencine(TM) (AgmaSet®) and WebSite (01/27/2010) - Product launch coinciding with the centennial of agmatine discovery - www.ForNerveHealth.com site was launched with an online store for marketing and selling AgmaSet® (previously NeurofencineTM).